Development of a Simple Method to Detect the Carbapenemase-Producing Genes bla NDM , bla OXA-48-like , bla IMP , bla KPC , and bla VIM Using a LAMP Method with Lateral Flow DNA Chromatography.
Kei MikitaMoe TajimaAnwarul HaqueYasuyuki KatoSatoshi IwataKoichi SuzukiNaoki HasegawaHisakazu YanoTetsuya MatsumotoPublished in: Diagnostics (Basel, Switzerland) (2024)
Infections by carbapenemase-producing Enterobacterales constitute a global public health threat. The rapid and efficient diagnosis of Enterobacterales infection is critical for prompt treatment and infection control, especially in hospital settings. We developed a novel loop-mediated isothermal amplification (LAMP) method combined with DNA chromatography to identify five major groups of carbapenemase-producing genes ( bla NDM , bla OXA-48-like , bla IMP , bla KPC , and bla VIM ). This method uses DNA-DNA hybridization-based detection in which LAMP products can be easily visualized as colored lines. No specific technical expertise, expensive equipment, or special facilities are required for this method, allowing its broad application. Here, 73 bacteria collections including strains with carbapenemase-producing genes were tested. Compared to sequencing results, LAMP DNA chromatography for five carbapenemase-producing genes had a sensitivity and specificity of 100% and >97%, respectively. This newly developed method can be a valuable rapid diagnostic test to guide appropriate treatments and infection control measures, especially in resource-limited settings.
Keyphrases
- klebsiella pneumoniae
- loop mediated isothermal amplification
- escherichia coli
- multidrug resistant
- sensitive detection
- circulating tumor
- single molecule
- public health
- cell free
- genome wide
- mass spectrometry
- nucleic acid
- drug resistant
- acinetobacter baumannii
- healthcare
- gene expression
- tandem mass spectrometry
- pseudomonas aeruginosa
- genome wide identification
- single cell
- dna methylation
- cystic fibrosis
- electronic health record
- transcription factor
- simultaneous determination
- adverse drug
- global health